Meanwhile, in a clinical trial of CIK cells combined with anti‐PD‐1 therapy performed by our team,[26] by retrospectively collecting PBMCs from patients with NSCLC before and after treatment. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.